Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer

被引:34
作者
Higaki, K [1 ]
Asai, M [1 ]
Suyama, T [1 ]
Nakayama, K [1 ]
Ogawara, K [1 ]
Kimura, T [1 ]
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Okayama 7008530, Japan
关键词
intradermal disposition; unbound fraction; multiregression analysis; penetration into muscular layer; systemic absorption; distribution from systemic circulation;
D O I
10.1016/S0378-5173(02)00084-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To develop a more efficient transdermal delivery system. it is very important to regulate the intradermal disposition of drugs after topical application, We tried to elucidate the factors determining the intradermal disposition kinetics, especially drug penetration from the viable skin to the muscular layer, mainly based on the six-compartment model, including the contralateral skin and muscle for ten model drugs with different physicochemical characteristics, In vivo transdermal absorption study was performed for six model drugs using the stripped-skin rats. The fitting analyses by the six-compartment model gave the theoretical curves describing the observed data very well and the reasonable pharmacokinetic parameters, showing the pharmacokinetic model should be useful for the estimation of the intradermal disposition kinetics of drugs applied topically again. The simulation study using the pharmacokinetic parameters obtained above Could show the relative contribution of the direct penetration and the distribution from the systemic circulation to the muscular distribution of drugs. The largest contribution of direct penetration was observed for antipyrine (90.8%) and the smallest was for felbinac (43.3%). Among the pharmacokinetic parameters obtained above, the clearance from the viable skin to the muscle (CLvs-m) was found to be significantly correlated with the unbound fraction of drugs in the viable skin (fu(vs)). Although the clearance from the viable skin to the plasma (CLvs p) also tended to increase as fu(vs) increased, the ratio of CLvs-m to CLvs-p was significantly correlated with fu(vs), meaning that the larger amount of unbound drug in the viable skin significantly contributes to the direct penetration into the muscle more than to the systemic absorption. On the other hand, k(direct) values obtained in in vitro penetration study-the penetration rate constant of drugs from the viable skin to the muscular layer-were found to be correlated with CLvs-m values for seven model drugs. Therefore, adding the in vitro experiments for other three model drugs, the multiple linear regression analysis of k(direct) was performed for ten model drugs in terms of fu(vs), logarithm of the partition coefficient (Log P) and molecular weight. The results clearly showed the largest and significant contribution of fu(vs) to the direct penetration of drugs from the viable skin to the muscular layer, indicating that a drug with the higher value of fu(vs) in the viable skin can penetrate more into the muscular layer. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:129 / 141
页数:13
相关论文
共 23 条
[1]  
CROSS SE, 1997, LANCET, V350, P363
[2]   THE DISPOSITION OF BIPHENYLACETIC ACID FOLLOWING TOPICAL APPLICATION [J].
DAWSON, M ;
MCGEE, CM ;
VINE, JH ;
NASH, P ;
WATSON, TR ;
BROOKS, PM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 (06) :639-642
[3]   FACILITATED TRANSPORT OF SODIUM-SALICYLATE ACROSS AN ARTIFICIAL LIPID-MEMBRANE BY AZONE [J].
HADGRAFT, J ;
WALTERS, KA ;
WOTTON, PK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (10) :725-727
[4]   ENHANCED DELIVERY OF MITOMYCIN-C DERIVATIVES THROUGH HAIRLESS MOUSE AND RAT SKINS [J].
HASHIDA, M ;
MUKAI, E ;
KIMURA, T ;
SEZAKI, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (08) :542-544
[5]  
M-Riviere N. A., 1993, PHARM RES, V10, P1326
[6]  
MARTY JP, 1989, PERCUTANEOUS ABSORPT, P511
[7]   Promoting effect of O-ethylmenthol on the percutaneous absorption of ketoprofen [J].
Nakamura, Y ;
Takayama, K ;
Higashiyama, K ;
Suzuki, T ;
Nagai, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 145 (1-2) :29-36
[8]   Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues [J].
Nakayama, K ;
Matsuura, H ;
Asai, M ;
Ogawara, K ;
Higaki, K ;
Kimura, T .
PHARMACEUTICAL RESEARCH, 1999, 16 (02) :302-308
[9]   PHARMACOKINETIC ANALYSIS OF DRUG ABSORPTION FROM MUSCLE BASED ON A PHYSIOLOGICAL DIFFUSION-MODEL - EFFECT OF MOLECULAR-SIZE ON ABSORPTION [J].
NARA, E ;
MASEGI, M ;
HATONO, T ;
HASHIDA, M .
PHARMACEUTICAL RESEARCH, 1992, 9 (02) :161-168
[10]   In vitro and in vivo evaluation of terpenoid esters of indomethacin as dermal prodrugs [J].
Palagiano, F ;
Arenare, L ;
Barbato, F ;
LaRotonda, MI ;
Quaglia, F ;
Bonina, FP ;
Montenegro, L ;
deCaprariis, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 149 (02) :171-182